Clinical Trial Update: A Phase II Randomized, Double-blind, Placebo-controlled Study of Sorafenib or Placebo in Combination With Transarterial Chemoembolization (TACE) Performed With DC Bead and Doxorubicin for Intermediate Stage Hepatocellular Carcinoma (HCC). [Phase 2]

View source ↗

Summary

Phase II randomized, double-blind, placebo-controlled study comparing sorafenib plus transarterial chemoembolization (TACE) with DC Bead-delivered doxorubicin t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• DC Bead (doxorubicin-eluting drug-eluting bead)
• Doxorubicin (doxorubicin)
• Sorafenib (Sorafenib)

Snippet

Sponsor: Bayer | Conditions: Carcinoma, Hepatocellular | Phase 2 | Status: COMPLETED | Results posted: 2012-09-24